相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer
Peter Blume-Jensen et al.
CLINICAL CANCER RESEARCH (2015)
A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy
Eric A. Klein et al.
EUROPEAN UROLOGY (2015)
Personalizing the Duration of Androgen-Deprivation Therapy Use in the Management of Intermediate-Risk Prostate Cancer
Anthony V. D'Amico
JOURNAL OF CLINICAL ONCOLOGY (2015)
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy
Robert B. Den et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Conditional Probability of Reclassification in an Active Surveillance Program for Prostate Cancer
Ridwan Alam et al.
JOURNAL OF UROLOGY (2015)
PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
Tamara L. Lotan et al.
MODERN PATHOLOGY (2015)
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial
Maria Pearse et al.
BJU INTERNATIONAL (2014)
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
M. Shipitsin et al.
BRITISH JOURNAL OF CANCER (2014)
Abstract 1086: MYC overexpression combined with Pten loss generates genomic instability and rapid metastasis in a new mouse model of lethal prostate adenocarcinoma.
Gretchen K. Hubbard et al.
CANCER RESEARCH (2014)
Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer
Neal Shore et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Cell cycle progression score and treatment decisions in prostate cancer : results from an ongoing registry
E. David Crawford et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
Eric A. Klein et al.
EUROPEAN UROLOGY (2014)
Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy
Robert B. Den et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer
Prabhakar Mithal et al.
INTERNATIONAL JOURNAL OF UROLOGY (2014)
Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
Stephen J. Freedland et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with Prostatectomy
Jay T. Bishoff et al.
JOURNAL OF UROLOGY (2014)
Prostate Cancer Ki-67 (MIB-1) Expression, Perineural Invasion, and Gleason Score as Biopsy-Based Predictors of Prostate Cancer Mortality: The Mayo Model
Matthew K. Tollefson et al.
MAYO CLINIC PROCEEDINGS (2014)
Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
Anna Bill-Axelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
A. E. Ross et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality
Michail Shipitsin et al.
PROTEOME SCIENCE (2014)
ERG induces taxane resistance in castration-resistant prostate cancer
Giuseppe Galletti et al.
NATURE COMMUNICATIONS (2014)
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2013)
Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
G. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Genetic markers associated with early cancer-specific mortality following prostatectomy
Wennuan Liu et al.
CANCER (2013)
Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
Katri A. Leinonen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
Stephen J. Freedland et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
An International Ki67 Reproducibility Study
Mei-Yin C. Polley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population
R. Jeffrey Karnes et al.
JOURNAL OF UROLOGY (2013)
Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO Guideline
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2013)
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
Nicholas Erho et al.
PLOS ONE (2013)
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2012)
An Immunohistochemical Signature Comprising PTEN, MYC, and Ki67 Predicts Progression in Prostate Cancer Patients Receiving Adjuvant Docetaxel After Prostatectomy
Emmanuel S. Antonarakis et al.
CANCER (2012)
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla et al.
LANCET (2012)
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Timothy J. Wilt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
Tamara L. Lotan et al.
CLINICAL CANCER RESEARCH (2011)
Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
Jeffrey J. Tosoian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Common Gene Rearrangements in Prostate Cancer
Mark A. Rubin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding et al.
NATURE (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer
Andrea B. Apolo et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Michael C. Haffner et al.
NATURE GENETICS (2010)
MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02
Li-Yan Khor et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
Adjuvant radiotherapy for pathologically advanced prostate cancer - A randomized clinical trial
Ian M. Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
PTEN function: how normal cells control it and tumour cells lose it
NR Leslie et al.
BIOCHEMICAL JOURNAL (2004)
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group trial 92-02
A Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
分享论文
